These data suggest that phosphorylation of Smad3 at Ser208 may allow LT-CML stem cells to activate Foxo3a, whose transcriptional activity supports CML stem cell maintenance in vivo15. Here, SMAD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.